Plenvu and Ischaemic cerebral infarction - a phase IV clinical study of FDA data

Summary:

Ischaemic cerebral infarction is reported only by a few people who take Plenvu.

The phase IV clinical study analyzes which people take Plenvu and have Ischaemic cerebral infarction. It is created by eHealthMe based on reports of 534 people who have side effects while taking Plenvu from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 06, 2023

534 people reported to have side effects when taking Plenvu.
Among them, 2 people (0.37%) have Ischaemic cerebral infarction.

What is Plenvu?

Plenvu has active ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate. eHealthMe is studying from 534 Plenvu users for its effectiveness, alternative drugs and more.

What is Ischaemic cerebral infarction?

Ischaemic cerebral infarction (ischemic stroke resulting from a disturbance in the blood vessels supplying blood to the brain) is found to be associated with 572 drugs and 287 conditions by eHealthMe.

Number of Plenvu and Ischaemic cerebral infarction reports submitted per year:

Could Plenvu cause Ischaemic cerebral infarction?

Gender of people who have Ischaemic cerebral infarction when taking Plenvu *:

female: 50 %
male: 50 %

Age of people who have Ischaemic cerebral infarction when taking Plenvu *:

Common drugs people take besides Plenvu *:

Xarelto: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Plenvu and have Ischaemic cerebral infarction?

Check whether Ischaemic cerebral infarction is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Ischaemic cerebral infarction and when was it recovered:

Ischaemic cerebral infarction in Plenvu

Expand to all the drugs that have ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate:

Ischaemic cerebral infarction and drugs with ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate

Alternative drugs to, pros and cons of Plenvu:

Plenvu (534 reports)

Common Plenvu side effects:

Nausea and vomiting: 165 reports

Browse all side effects of Plenvu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Ischaemic cerebral infarction treatments and more:

Ischaemic cerebral infarction (1,450 reports)

COVID vaccines that are related to Ischaemic cerebral infarction:

Common drugs associated with Ischaemic cerebral infarction:

Xarelto: 109 reports

How the study uses the data?

The study uses data from the FDA. It is based on ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate (the active ingredients of Plenvu) and Plenvu (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.